Statement of Changes in Beneficial Ownership (4)
October 02 2020 - 05:15PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL
OWNERSHIP OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
1. Name
and Address of Reporting Person * DARGAN CHARLES
K |
2. Issuer Name and Ticker or Trading
Symbol BIOLARGO, INC. [ BLGO ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)_____
Director _____
10% Owner
__X__ Officer (give title
below) _____ Other
(specify below)
Chief Financial Officer |
(Last)
(First)
(Middle)
18851 NE 29TH AVENUE, SUITE 700 |
3. Date of Earliest Transaction (MM/DD/YYYY)
9/30/2020
|
(Street)
AVENTURA, FL 3318
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
|
1.Title of Security
(Instr. 3) |
2. Trans. Date |
2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following
Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
Amount |
(A) or (D) |
Price |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative
Security |
3. Trans. Date |
3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or
Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying
Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially
Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct
(D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Option to purchase common
stock |
$0.15 |
9/30/2020 |
|
A |
|
5000 |
|
9/30/2020 |
9/30/2030 |
Common stock |
5000 |
$0 (1) |
3618286 (2) |
D |
|
Explanation of
Responses: |
(1) |
This Option was granted to
Reporting Person to replace options to purchase 20,000 shares that
had been issued approximately 10 years ago to compensate Reporting
Person for services to the Issuer and had recently expired
unexercised due to a discrepancy between the original exercise
price and the Issuer's current stock price, pursuant to plan
adopted by the Issuer's Compensation Committee. |
(2) |
This amount reflects, in
addition to the reported option, grant, the expiration on July 31,
2020 and August 31, 2020, of options to purchase an aggregate
20,000 shares of common stock. |
Reporting
Owners
|
Reporting Owner Name / Address |
Relationships
|
Director |
10% Owner |
Officer |
Other |
DARGAN CHARLES K
18851 NE 29TH AVENUE
SUITE 700
AVENTURA, FL 3318 |
|
|
Chief Financial Officer |
|
Signatures
|
/s/ John R. Browning,
Attorney-in-fact |
|
10/2/2020 |
**Signature of
Reporting Person |
Date |